OPKO Health (OPK) Tops Q2 EPS by 4c, beats revenue
Tweet
Share
E-mail
Get Alerts OPK Hot Sheet
Price: $1.64 +1.86%
Revenue Growth %: -11.2%
Financial Fact:
Net loss attributable to common Shareholders: -14.98M
Today's EPS Names:
PMCB, CULP, HURC, More
Revenue Growth %: -11.2%
Financial Fact:
Net loss attributable to common Shareholders: -14.98M
Today's EPS Names:
PMCB, CULP, HURC, More
Join SI Premium – FREE
OPKO Health (NASDAQ: OPK) reported Q2 EPS of ($0.03), $0.04 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $265.4 million versus the consensus estimate of $201.97 million.
For earnings history and earnings-related data on OPKO Health (OPK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Lynx Equity sees Micron and SanDisk breakout as volatility normalizes
- TSX movers: VersaBank jumps 10% as corporate catalysts lift top gainers
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
